Benefits of second generation TKIs for CML in the frontline

Benefits of second generation TKIs for CML in the frontline

VJHemOnc

1 year
94 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Giuseppe Saglio, MD, of the University of Turin, Turin, Italy, discusses the benefits of second generation TKIs for the frontline treatment of chronic myeloid leukemia (CML). These more potent inhibitors have reduced the rate of disease progression, being able to suppress certain clones that are resistant to imatinib. Dr Saglio highlights how these TKIs induce fast and deep responses; a very important property, even in low-risk patients. This interview was recorded at the 2018 Society of Hematologic Oncology (SOHO) Annual Meeting held in Houston, TX.
Up Next Autoplay
CML Ponatinib vs Bosutinib: What is Next for Research? #ASH19 @TakedaOncology
CML Ponatinib vs Bosutinib: What is Next for Research? #ASH19 @TakedaOncology
Category: Chronic Myelogenous Leukemia
23 Views
ash 1 month
CML Patients Prescribed Ponatinib Vs Bosutinib #ASH19 @TakedaOncology
CML Patients Prescribed Ponatinib Vs Bosutinib #ASH19 @TakedaOncology
Category: Chronic Myelogenous Leukemia
63 Views
ash 1 month
Brentuximab Vedotin with Chemotherapy #ASH19
Brentuximab Vedotin with Chemotherapy #ASH19
Category: Chronic Myelogenous Leukemia
7 Views
ash 1 month
Modeling Responses When Testing Less Frequently Than Monthly After Stopping Therapy
Modeling Responses When Testing Less Frequently Than Monthly After Stopping Therapy
Category: Chronic Myelogenous Leukemia
14 Views
iCMLf 1 month
Perspectives on the Future of CML
Perspectives on the Future of CML
Category: Chronic Myelogenous Leukemia
44 Views
iCMLf 1 month
Re-evaluating TKI in CML Patients During Pregnancy
Re-evaluating TKI in CML Patients During Pregnancy
Category: Chronic Myelogenous Leukemia
6 Views
iCMLf 1 month
CML and Pregnancy
CML and Pregnancy
Category: Chronic Myelogenous Leukemia
13 Views
iCMLf 1 month
Treating CML & Myelofibrosis Patients
Treating CML & Myelofibrosis Patients
Category: Chronic Myelogenous Leukemia
321 Views
imedex 1 year
Resistance/intolerance to second generation TKIs in CML: what to do next?
Resistance/intolerance to second generation TKIs in CML: what to do next?
Category: Chronic Myelogenous Leukemia
157 Views
VJHemOnc 1 year
Update on ENESTop: TFR in CML after discontinuing nilotinib
Update on ENESTop: TFR in CML after discontinuing nilotinib
Category: Chronic Myelogenous Leukemia
149 Views
VJHemOnc 1 year